COL1A1 and osteogenesis imperfecta: We suppose that this data may advance the understanding of the OI genetic epidemiology; broaden current knowledge about the spectrum of COL1A1/2 pathogenic variants, patient’s phenotypes, and clinical manifestations; and help to estimate the scope of genotype-phenotype correlations.